Abstract:Son Trinh The, 1, &ast Sang Trieu Tien, 2, &ast Tam Vu Van, 3, 4 Nhat Nguyen Ngoc, 1 My Tran Ngoc Thao, 5 Khoa Tran Van, 2 Dinh Vu Nhat, 6, 7 Binh Do Nhu 8, 9 1 Military Institute of Clinical Embryology and Histology, Vietnam Military Medical University, Hanoi, 12108, Vietnam; 2 Department of Biology and Genetics, Vietnam Military Medical University, Hanoi, 12108, Vietnam; 3 Director Office, Hai Phong Hospital of Obstetrics and Gynecology, Haiphong, 40000, Vietnam; 4 Obstetrics and Gynecology Department of Haiphong University of Medicine and Pharmacy, Haiphong, 40000, Vietnam; 5 Département de formation Biologie moléculaire et cellulaire, Sorbonne University, Paris, 75006, France; 6 Director Office, Military Hospital 103, Hanoi, 12108, Vietnam; 7 Department of Trauma and Orthopedic Surgery, Vietnam Military Medical University, Hanoi, 121– 08, Vietnam; 8 Division of Military Science, Military Hospital 103, Hanoi, 12108, Vietnam; 9 Department of Infectious Disease, Vietnam Military Medical University, Hanoi, 12108, Vietnam &astThese authors contributed equally to this work Correspondence: Dinh Vu Nhat Military Hospital 103, Hanoi, 12108, Vietnam Email Background: Adrenoleukodystrophy (ALD) is a rare sex-linked recessive disorder that disrupts adrenal gland function and the white matter of the nervous system. According to recent epidemiological statistics, up to this moment, the disease is the most recorded peroxisomal disorder. ABCD1 is a gene related to ALD, with more than 850 unique mutations have been reported. Early diagnosis of the disease would help to consult families with ALD to plan for interventions to prevent passing along the pathogenic mutations to their children. Material and Methods: A heterozygous ABCD1 gene mutation related to ALD found in a Vietnamese woman was used to design primers for the polymerase chain reaction (PCR) to amplify the segment spanning the mutation. Then, combining sequencing methods for the PCR products, especially Sanger sequencing and next-generation sequencing (NGS), a protocol was developed to detect mutations on the ABCD1 gene to apply for the DNA samples of in-vitro fertilization (IVF) embryos biopsied at the blastocyst stage to screen for pathogenic alleles. Results: The established protocol for PGD of ALD detected mutant alleles in 5/8 embryos (62.5%), while the remaining 3 embryos (37.5%) did not carry any mutation. One of the 3 embryos was transferred, and a healthy female baby was born after a full-term pregnancy. Conclusion: The developed protocol was helpful for the preimplantation genetic diagnosis process to help families with the monogenic disease of ALD but wish to have healthy children. Keywords: adrenoleukodystrophy, ALD, peroxisome disorder, ABCD1 gene mutation, preimplantation genetic diagnosis, PGD ALD is a rare sex-linked hereditary disease with the incidence dropped between 1:20,000 and 1:30,000 male newborns, without significant differences among countries and ethnic groups globally; however, this figure is increasing prior to the widespread application of newborn screening. Mutations in the ABCD1 gene are the pathogenic factors leading to the impaired β-oxidation process in peroxisomes. All patients with ALD carry the mutations; up to date, more than 850 non-recurrent mutations of this disease have been cataloged without correlation to phenotypes. 1–3 The gene ABCD1 is located near the end of the X chromosome's long arm: at Xq28 and has a length of 19.9 kb with 10 exons. 4 , 5 ABCD1 encodes a transmembrane protein made up of 745 amino acids called adrenoleukodystrophy protein, or ALDP. This protein is located across the peroxisome membrane, transporting VLCFA (very long chain fatty acids) from the cytoplasm through the membrane into the organelle to participate in the β-oxidation process. 6–8 Mutations in the ABCD1 gene will directly affect the ALD protein, result in a change in the protein's structure and quantity, making it unable to carry out its transport function, thereby causing the accumulation of VLCFA in the cytoplasm. This accumulation has negative effects on cells, especially on nervous system cells. 1 , 9 , 10 There are three main phenotypes of ALD that can be listed as follows: cerebral ALD, adrenomyel -Abstract Truncated-

Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model

Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy

A Novel Mouse Model for Cerebral Inflammatory Demyelination in X‐Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets

In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model

Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer's disease.

Hematopoietic stem cell therapy and ex vivo gene therapy for X-linked adrenoleukodystrophy

Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy

From gene to therapy: a review of deciphering the role of ABCD1 in combating X-Linked adrenoleukodystrophy

Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy

Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy

Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes

AAV9-MCT8 delivery at juvenile stage ameliorates neurological and behavioral deficits in a mouse model of MCT8-deficiency

Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice

A blood-brain-barrier penetrant AAV gene therapy rescues neurological deficits in mucolipidosis IV mice

A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

Abstract TMP3: Overexpression of Alk1 in Brain Endothelial Cells Alleviates the Severity of Brain Arteriovenous Malformations in Alk1 Mutant Mice

Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic Integrations

An in vitro and in vivo efficacy evaluation of a novel gene therapy candidate (SBT101) in mouse models of adrenomyeloneuropathy and in NHPs

Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transfer

Successful Pregnancy Following Preimplantation Genetic Diagnosis of Adrenoleukodystrophy by Detection of Mutation on the ABCD1 Gene